Genetic Deletion of Galectin-3 Does Not Impair Full-Thickness Excisional Skin Healing

Journal of Investigative Dermatology

Volumn 136, Issue 5, 2016, Pages 1042-1050

  Walker, John T ^a   Elliott, Christopher G ^a   Forbes, Thomas L ^a   Hamilton, Douglas W ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC WOUND; CONTROLLED STUDY; EPITHELIZATION; FIBROBLAST; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MOUSE; MYOFIBROBLAST; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; SKINFOLD THICKNESS; WOUND CLOSURE; WOUND HEALING; WOUND TISSUE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; INJURIES; INJURY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; SKIN; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROBLASTS; GALECTIN 3; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; SKIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84978069396     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.01.014     Document Type: Article

References (49)

1. Barondes, S.H., Cooper, D.N.W., Gitt, M.A., Leffler, H., Galectins: structure and function of a large family of animal lectins. J Biol Chem 269 (1994), 20807–20810.
2. Cao, Z.Y., Said, N., Amin, S., Wu, H.K., Bruce, A., Garate, M., et al. Galectins-3 and-7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem 277 (2002), 42299–42305.
3. D'Haene, N., Sauvage, S.S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., et al. VEGFR1 and VEGFR2 involvement in extracellular galectin-1-and galectin-3-induced angiogenesis. PLoS One, 8, 2013, e67029.
4. Desmoulière, A., Geinoz, A., Gabbiani, F., Gabbiani, G., Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122 (1993), 103–111.
5. Dovi, J.V., He, L.K., DiPietro, L.A., Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73 (2003), 448–455.
6. Elliott, C.G., Forbes, T.L., Leask, A., Hamilton, D.W., Inflammatory microenvironment and tumor necrosis factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds and dermal fibroblasts. Matrix Biol 43 (2015), 71–84.
7. Elliott, C.G., Wang, J., Guo, X., Xu, S., Eastwood, M., Guan, J., et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci 125 (2012), 121–132.
8. Gál, P., Vasilenko, T., Kostelníková, M., Jakubčo, J., Kováč, I., Sabol, F., et al. Open wound healing in vivo: monitoring binding and presence of adhesion/growth-regulatory galectins in rat skin during the course of complete re-epithelialization. Acta Histochem Cytochem 44 (2011), 191–199.
9. Goldberg, M.T., Han, Y.-P., Yan, C., Shaw, M.C., Garner, W.L., TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 127 (2007), 2645–2655.
10. Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Kipari, T., Haslett, C., Iredale, J.P., et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172 (2008), 288–298.
11. Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Poirier, F., Russo, F.P., Iredale, J.P., et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103 (2006), 5060–5065.
12. Hothorn, T., Bretz, F., Westfall, P., Simultaneous inference in general parametric models. Biom J 50 (2008), 346–363.
13. Jaguin, M., Houlbert, N., Fardel, O., Lecureur, V., Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol 281 (2013), 51–61.
14. Jia, W., Kidoya, H., Yamakawa, D., Naito, H., Takakura, N., Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors. Am J Pathol 182 (2013), 1821–1831.
15. Jiang, J.X., Chen, X., Hsu, D.K., Baghy, K., Serizawa, N., Scott, F., et al. Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. AJP Gastrointest Liver Physiol 302 (2012), G439–G446.
16. Johnson, A., Di Pietro, L.A., Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J 27 (2013), 3893–3901.
17. Karlsson, A., Christenson, K., Matlak, M., Björstad, Å., Brown, K.L., Telemo, E.E., et al. Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology 19 (2009), 16–20.
18. Li, Q., Yu, Y., Bischoff, J., Mulliken, J.B., Olsen, B.R., Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol 201 (2003), 296–302.
19. Lim, M.J., Ahn, J., Yi, J.Y., Kim, M.-H.H., Son, A.-R.R., Lee, S.L.O., et al. Induction of galectin-1 by TGF-beta 1 accelerates fibrosis through enhancing nuclear retention of Smad2. Exp Cell Res 326 (2014), 125–135.
20. Liu, W., Hsu, D.K., Chen, H.-Y., Yang, R.-Y., Carraway, K.L., Isseroff, R.R., et al. Galectin-3 regulates intracellular trafficking of EGFR through alix and promotes keratinocyte migration. J Invest Dermatol 132 (2012), 2828–2837.
21. Machado, C.M.L., Andrade, L.N.S., Teixeira, V.R., Costa, F.F., Melo, C.M., Dos Santos, S.N., et al. Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Med 3 (2014), 1–14.
22. MacKinnon, A.C., Farnworth, S.L., Hodkinson, P.S., Henderson, N.C., Atkinson, K.M., Leffler, H., et al. Regulation of alternative macrophage activation by galectin-3. Thorax, 63, 2008, A26.
23. MacKinnon, A.C., Gibbons, M.A., Farnworth, S.L., Leffler, H., Nilsson, U.J., Delaine, T., et al. Regulation of transforming growth factor-beta 1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med 185 (2012), 537–546.
24. Madsen, D.H., Leonard, D., Masedunskas, A., Moyer, A., Jürgensen, H.J., Peters, D.E., et al. M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol 202 (2013), 951–966.
25. Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem 286 (2011), 29913–29921.
26. Markowska, A.I., Liu, F.-T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med 207 (2010), 1981–1993.
27. Martinez, F.O., Gordon, S., Locati, M., Mantovani, A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177 (2006), 7303–7311.
28. Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156 (2000), 899–909.
29. Nangia-Makker, P., Wang, Y., Raz, T., Tait, L., Balan, V., Hogan, V., et al. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer. Int J Cancer 127 (2010), 2530–2541.
30. Nelson, E.A., Bradley, M.D., Dressings and topical agents for arterial leg ulcers. Cochrane Database Syst Rev, 2007 CD001836.
31. Novak, R., Dabelic, S., Dumic, J., Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim Biophys Acta 1820 (2012), 1383–1390.
32. Pepe, D., Elliott, C.G., Forbes, T.L., Hamilton, D.W., Detection of galectin-3 and localization of advanced glycation end products (AGE) in human chronic skin wounds. Histol Histopathol 29 (2014), 251–258.
33. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team. {nlme}: linear and nonlinear mixed effects models. R package version 3.1-121, http://CRAN.R-project.org/package=nlme; 2015.
34. Pugliese, G., Iacobini, C., Ricci, C., Fantauzzi, C.B., Galectin-3 in diabetic patients. Clin Chem Lab Med 52 (2014), 1413–1423.
35. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, http://www.R-project.org/; 2015.
36. Reinke, J.M., Sorg, H., Wound repair and regeneration. Eur Surg Res 49 (2012), 35–43.
37. Rittié, L., Fisher, G.J., Isolation and culture of skin fibroblasts. Methods Mol Med 117 (2005), 83–98.
38. Sano, H., Hsu, D.K., Apgar, J.R., Yu, L., Sharma, B.B., Kuwabara, I., et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112 (2003), 389–397.
39. Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9 (2012), 671–675.
40. Schultz, G.S., Wysocki, A., Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17 (2009), 153–162.
41. Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., et al. Human skin wounds: a major and snowballing threat to public health and the economy: perspective article. Wound Repair Regen 17 (2009), 763–771.
42. Shih, S.-C., Robinson, G.S., Perruzzi, C.A., Calvo, A., Desai, K., Green, J.E., et al. Molecular profiling of angiogenesis markers. Am J Pathol 161 (2002), 35–41.
43. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122 (2012), 787–795.
44. Singer, A.J., Clark, R.A.F., Mechanisms of disease: cutaneous wound healing. N Engl J Med 341 (1999), 738–746.
45. Taylor, M.W., Feng, G.S., Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5 (1991), 2516–2522.
46. Widgerow, A.D., Chronic wound fluid-thinking outside the box. Wound Repair Regen 19 (2011), 287–291.
47. Wiegand, C., Schönfelder, U., Abel, M., Ruth, P., Kaatz, M., Hipler, U.-C., Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 302 (2010), 419–428.
48. Wong, V.W., Sorkin, M., Glotzbach, J.P., Longaker, M.T., Gurtner, G.C., Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol, 2011, 2011, 969618.
49. Wynn, T., Cellular and molecular mechanisms of fibrosis. J Pathol 214 (2008), 199–210.